Covid-19 Pharma News
Biomarkers discovered for SARS-CoV-2 acute infections and Long COVID
Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quantified newly discovered biomarkers of SARS-CoV-2 acute infections and of ‘Long COVID’. Read more
21 Sep 2022
Bivalent COVID-19 booster vaccine approved in UK
The COVID-19 vaccine, by Moderna, has been adapted to target two different COVID-19 variants; the original 2020 virus and the Omicron variant. The MHRA has approved the bivalent vaccine for adult booster doses in the UK. Read more
16 Aug 2022
![New Hampshire Public Health Laboratories uses the ASSIST PLUS and MINI 96[37] copy.png](https://pharmaceuticalmanufacturer.media/downloads/8940/download/New%20Hampshire%20Public%20Health%20Laboratories%20uses%20the%20ASSIST%20PLUS%20and%20MINI%2096%5B37%5D%20copy.png?cb=c7b3ae3b2755ac0f572391fcdbd96017&w=640 "New Hampshire Public Health Laboratories uses the ASSIST PLUS and MINI 96[37] copy.png")
INTEGRA semi-automation prevents SARS-CoV-2 testing backlog
New Hampshire Public Health Laboratories (NHPHL) has adopted INTEGRA Biosciences’ ASSIST PLUS pipetting robot and MINI 96 portable electronic pipette to automate part of its influenza and SARS-CoV-2 testing process. Read more
3 Aug 2022
Vaccizone selects Exothera for GMP manufacturing of its SARS‑CoV‑2 vaccine
Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS‑CoV‑2 vaccine for European clinical trials. Read more
25 Jul 2022
Pfizer and BioNTech announce high immune response against Omicron
Pfizer and BioNTech SE announce positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates against the Omicron variant. Read more
13 Jul 2022
Bruker launches NMR test for research into Long COVID treatments
Bruker Corporation has launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, for research into treating patients suffering from Long Covid. Read more
8 Jul 2022
![New Hampshire Public Health Laboratories uses the ASSIST PLUS and MINI 96[37] copy.png](https://pharmaceuticalmanufacturer.media/downloads/8940/download/New%20Hampshire%20Public%20Health%20Laboratories%20uses%20the%20ASSIST%20PLUS%20and%20MINI%2096%5B37%5D%20copy.png?cb=c7b3ae3b2755ac0f572391fcdbd96017&w={width}&h={height} "New Hampshire Public Health Laboratories uses the ASSIST PLUS and MINI 96[37] copy.png")
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks. Read more
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics. Read more
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics. Read more
26 Jul 2022
Sponsored Content
Vaccine skin patch receives second round funding grant
Vaxxas will receive an AU$8.2 million second round grant as part of the Australian Federal Government’s Modern Manufacturing Initiative (MMI) to support the manufacturing scale-up of its vaccine delivery technology. Read more
28 Sep 2022
AstraZeneca treatment lowers cardiovascular death in HF patients
AstraZeneca recently released results from two key studies at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain, validating the clinical value and differentiation of FARXIGA in treating patients living with heart failure. Read more
28 Sep 2022
WuXi opens first high potency oral drug product manufacturing facility
WuXi STA, a global CRDMO, announced the opening of its first high potency (HP) oral drug product manufacturing facility at its Wuxi city campus. This new facility allows WuXi STA to further extend its drug product capacity and capabilities. Read more
28 Sep 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Bora division partners with TaiRx to manufacture anticancer drug
Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals has partnered with TaiRx, a Taiwan new drug development company, to manufacture a novel anticancer drug, CVM-1118. Read more
27 Sep 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
![_DSC1196 copy-min-min[94].png](https://pharmaceuticalmanufacturer.media/downloads/9107/download/_DSC1196%20copy-min-min%5B94%5D.png?cb=6027715905cf4c9b56b68f3cb0ccf2d5&w=640 "_DSC1196 copy-min-min[94].png")
Peli BioThermal opens new service centre in Japan
Peli BioThermal, the life science industry’s partner from discovery to distribution, announces the opening of its new service center in Japan. The new facility is ideally situated near Tokyo’s international Narita Airport. Read more
27 Sep 2022
Pharma Manufacturing News + Pharma Finance and Investment News
BioIVT acquires Fidelis Research to expand biospecimen capabilites
BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired Fidelis Research, an 85-site clinical biospecimen collection network in Southeastern Europe with headquarters in Sofia, Bulgaria. Read more
27 Sep 2022
![_DSC1196 copy-min-min[94].png](https://pharmaceuticalmanufacturer.media/downloads/9107/download/_DSC1196%20copy-min-min%5B94%5D.png?cb=6027715905cf4c9b56b68f3cb0ccf2d5&w={width}&h={height} "_DSC1196 copy-min-min[94].png")
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
White Papers
Sponsored Content
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
GEKA Healthcare
GEKA HEALTHCARE creates innovative solutions for extremely precise and hygienic application systems Read more
